Santaris Pharma a s - PDFSEARCH.IO - Document Search Engine

Santaris Pharma a s
Results: 7

#	Item
1	spin-out companies asklepios biopharmaceutical Therapeutic \| askbio.com Asklepios BioPharmaceutical Inc., (“AskBio”) is a biotechnology company co-founded by R. Jude Samulski, Add to Reading List Source URL: partnerships.unc.edu Language: English - Date: 2014-06-23 12:00:32 Drug discovery Biologic Santaris Pharma a/s Trubion Pharmaceutical sciences Pharmacology UNC Eshelman School of Pharmacy
2	Breakthrough for treatment of cancer, and other diseases InteRNA Technologies BV is a Utrecht based biotech company that is developing new therapeutics for cancer and other diseases. The approach is based on science deve Add to Reading List Source URL: www.innovatieindezorg.com Language: English - Date: 2014-06-19 03:55:46 MicroRNA Melanoma Drug discovery Rosetta Genomics Santaris Pharma a/s Pharmaceutical sciences Pharmacology Regulus Therapeutics
3	Assessing unintended hybridization induced biological effects of oligonucleotides Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-08 14:21:08 Chemistry Nucleic acids Biotechnology Santaris Pharma a/s Laboratory techniques Small interfering RNA Oligonucleotide In silico Polymerase chain reaction Biology Genetics RNA
4	Oligonucleotide drug discovery at Santaris Pharma + emphasis on specificity Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-01-08 14:21:16 MicroRNA MiR-122 Santaris Pharma a/s Oligonucleotide Small interfering RNA Non-coding RNA Morpholino Locked nucleic acid Genetics RNA Biology
5	RNA OLIGONUCLEOTIDES: EMERGING CLINICAL APPLICATIONS NATIONAL INSTITUTES OF HEALTH HILTON HOTEL, ROCKVILLE, MARYLAND DECEMBER 15-16, 2011 AGENDA Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2014-03-20 16:29:33 Santaris Pharma a/s Joshua T. Mendell Small interfering RNA Genetics RNA MicroRNA
6	Santaris Pharma A/S Phase 2a data of miravirsen shows dose-dependent, prolonged viral reduction of 2-3 logs HCV RNA after four-week treatment in Hepatitis C patients -- New Phase 2a clinical data to be presented in late-breaking oral presentation at AASLD – Add to Reading List Source URL: www.santaris.com Language: English - Date: 2011-11-05 11:55:33 MicroRNA RNA Antivirals Santaris Pharma a/s MiR-122 Hepatitis C virus Locked nucleic acid Hepatitis C Hepatitis B Genetics Biology Medicine
7	PDF Document Add to Reading List Source URL: www.ebiotrade.com Language: English - Date: 2009-05-08 04:08:20 Nucleic acids RNA Santaris Pharma a/s Locked nucleic acid Antisense therapy Sense Applera Applied Biosystems Oligonucleotide Biology Pharmaceutical sciences Genetics